PF-Atlas › Clinical Trials › NCT06267183
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
SV001 · Early Phase 1
Registry ID
NCT06267183
Phase
Early Phase 1
Status
Recruiting
Drug / intervention
SV001
Sponsor
Shanghai Synvida Biotechnology Co.,Ltd.
Start
2024-01-12
Enrollment
53
Locations
1
About this trial
The purpose of this study is to evaluate safety, tolerability, PK and immunogenicity of SV001 compare to placebo in Chinese healthy adult volunteers.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT06267183 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.